Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial. [electronic resource]
Producer: 20191223Description: 1755-1762 p. digitalISSN:- 1569-8041
- Administration, Oral
- Adult
- Aged
- Antineoplastic Agents -- pharmacology
- Biopsy
- Breast -- pathology
- Breast Neoplasms -- pathology
- Cell Proliferation -- drug effects
- Cyclin-Dependent Kinase 4 -- antagonists & inhibitors
- Cyclin-Dependent Kinase 6 -- antagonists & inhibitors
- Drug Resistance, Neoplasm
- Female
- Humans
- Ki-67 Antigen -- analysis
- Middle Aged
- Neoadjuvant Therapy -- methods
- Phosphorylation -- drug effects
- Piperazines -- pharmacology
- Pyridines -- pharmacology
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Retinoblastoma Binding Proteins -- metabolism
- Treatment Outcome
- Ubiquitin-Protein Ligases -- metabolism
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.